EFN

According to a recent study, taking aspirin after the completion of breast cancer treatment lowers the patient’s risk of dying or having cancerous tumors migrate to other parts of the body. In fact, this study, which gathered information from 4,164 nurses, showed that those who took aspirin reduced their risk by over 50 percent. This study was published online in the Journal of Clinical Oncology.

According to the author of the study, Michelle Holmes, aspirin is effective at lowering these risks and controlling breast cancer because it reduced inflammation in the body. Patients with breast cancer have more inflammatory cells than those who do not have the cancer. Aspirin has also been shown to prevent tumor cells from breast cancer from growing and invading other parts of the body.

Those patients who decide to embark on an aspirin regimen should be sure to consult with their doctor before starting this treatment. Aspirin can cause gastrointestinal bleeding and thinning of the blood, both of which can be very harmful. Further studies need to be conducted into the subject of aspirin therapy for breast cancer treatment. It is important that breast cancer patients not try to use aspirin in place of traditional cancer treatment. Aspirin therapy should be considered after all other treatments have been completed.